Miconazole: A Review of its Antifungal Activity and Therapeutic Efficacy

@article{Sawyer2012MiconazoleAR,
  title={Miconazole: A Review of its Antifungal Activity and Therapeutic Efficacy},
  author={Phyllis R. Sawyer and Rex N. Brogden and Roger Martin Pinder and Trevor M. Speight and Graeme S. Avery},
  journal={Drugs},
  year={2012},
  volume={9},
  pages={406-423}
}
SummaryMiconazole2, a synthetic imidazole derivative, is a new topical antifungal agent for use in the local treatment of vaginal, and skin and nail infections due to yeasts and dermatophytes. It is particularly active against Candida spp., Trichophyton spp., Epidermophyton spp., Microsporum spp. and Pityrosporon orbiculare (Malassezia furfur), but also possesses some activity against Gram-positive bacteria.In vaginal candidiasis, miconazole vaginal cream has produced higher cure rates than… Expand
Miconazole: A Preliminary Review of its Therapeutic Efficacy in Systemic Fungal Infections
TLDR
In in vivo studies, intramuscular miconazole markedly increased the survival rate of rats with experimental systemic candidosis compared with placebo controls, and increased survival of mice infected with Coccidioides immitis, however, subcutaneous and intraperitoneal administration were ineffective in treating miceinfected with Cryptococcus neoformans. Expand
Antifungal Agents Used in Systemic Mycoses
TLDR
With the imidazoles, the authors have entered a new era of antifungal therapy which may produce even better antIFungal agents than those currently available, and two members, miconazole and ketoconazole, are promising agents. Expand
Treatment and Prophylaxis of Tinea Infections
TLDR
The modern formulations fully meet the requirements of being well tolerated, involving little risk and acting specifically against relevant pathogens, however, the response rates to date do not always come up to the high expectations offered by in vitro studies. Expand
Miconazole, a pharmacological barrier to skin fungal infections
TLDR
Miconazole is characterized by high safety, efficacy and versatility, and a unique, multifaceted nature of activity in the treatment of dermatomycoses, and exhibits a fungicidal effect against a number of fungal species, due to hydrogen peroxide accumulation. Expand
An Overview of Topical Antifungal Therapy in Dermatomycoses
TLDR
It is important to confirm mycologically the clinical diagnosis of onychomycosis and other tinea infections prior to commencing therapy, and the identity of the fungal organism may provide guidance about the appropriateness of a given topical antifungal agent. Expand
New insights on the antibacterial efficacy of miconazole in vitro
TLDR
Topically applied miconazole might be a therapeutic option in skin infections especially caused by gram‐positive bacteria even by those strains which are resistant to antibiotics. Expand
NOVEL CARRIERS IN TOPICAL ANTIFUNGAL THERAPY OF MICONAZOLE
Fungal infections are amongst the most commonly encountered dermatological diseases in worldwide. The topical route is generally preferred due to the possible side effects of oral medication.Expand
Mucoadhesive Potential of Whey Protein Concentrate in Miconazole Mucoadhesive Prolong Release Tablets
Orophygial candidiasis (OPC) is one of the most frequent Candida infections of the oral cavity this condition is common in patients with malnutrition, having chemotherapy, administratingExpand
Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs.
TLDR
Initial clinical evaluation has produced responses to therapy with 200-400 mg/day in 13 of 16 evaluable patients with systemic and superficial fungal infections, involving 10 fungal pathogens. Expand
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
TLDR
All the nine new compounds tested appear to offer reasonable potential for antifungal chemotherapy in vivo, according to RIF data, which tended to show most of the new antIFungals in a very poor light. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 147 REFERENCES
Topical Pharmacology of Imidazole Antifungals
  • R. Holt
  • Medicine
  • Journal of cutaneous pathology
  • 1976
TLDR
The relative value of these topical agents is discussed, and it is suggested that in severe and extensive dermatomycoses consideration should be given to the systemic use of miconazole in support of topical therapy. Expand
Recent developments in antimycotic chemotherapy
TLDR
It is suggested that at present 5 FC is the drug of choice for candidosis and cryptococcosis, providing careful laboratory monitoring is maintained, while clotrimazole or miconazole is preferable in the therapy of lung aspergilloses. Expand
Antimicrobial activity of econazole and miconazole in vitro and in experimental candidiasis and aspergillosis.
TLDR
It is concluded that more studies, especially on the pharmacology of econazole and about the clinical efficacy, are needed to come to a definite judgement. Expand
Miconazole, a New Broad‐spectrum Antimycotic, in the Treatment of Vaginal Candidosis
TLDR
The first trial of the new compound, miconazole, against vaginal candidosis is reported, with results that indicate it is effective against gram-negative bacteria and not absorbed when administered topically or iiitravaginally. Expand
Clinical studies on clotrimazole as antifungal therapy in obstetrics and gynaecology.
TLDR
An antifungal potency for the vaginal tablets (100 mg.) comparable with that of other antIFungal vaginal tablets, as determined in vitro, is indicated. Expand
In Vitro Antifungal Activity of Clotrimazole (Bay b 5097)
  • S. Shadomy
  • Medicine, Biology
  • Infection and immunity
  • 1971
TLDR
The in vitro antifungal activity of clotrimazole was compared with those of amphotericin B, griseofulvin, nystatin, and pyrrolnitrin, and the size of inoculum was shown to have a significant effect on the results of in vitro susceptibility testing with clotrimzole. Expand
Laboratory assessment of the antimycotic drug clotrimazole
TLDR
Cl clotrimazole may be the first of a long series of imidazole derivatives with varying pharmacological and therapeutic properties, and the significance of low levels of the drug in body fluids, even after prolonged therapy, is discussed. Expand
Chemotherapeutic evaluation of clotrimazole (Bay b 5097, 1 (o-chloro- - -diphenylbenzyl) imidazole).
TLDR
In vitro, but not in vivo, some gram-positive and gram-negative bacteria are inhibited by low concentrations of clotrimazole, and Pretreatment with the agent may decrease its efficacy because of drug inactivation. Expand
Topical Treatment of Dermatomycoses with Canesten® * ) Cream, a New Antimycotic Compound
TLDR
Since 1958 topical application could be combined with oral medication of griseofulvin and better results were therefore obtained especially in the treatment of tinea capitis, favus and tinea due to T . Expand
Bilogical and toxicological properties of econazole, a broad-spectrum antimycotic.
TLDR
Toxicity and teratogenicity studies in different laboratory animals indicate that econazole is well tolerated. Expand
...
1
2
3
4
5
...